Topical and Transdermal Delivery of L-Carnitine

被引:10
|
作者
Fox, L. T. [1 ]
Gerber, M. [1 ]
du Preez, J. L. [1 ]
Grobler, A. [1 ]
du Plessis, J. [1 ]
机构
[1] North West Univ, Unit Drug Res & Dev, ZA-2520 Potchefstroom, South Africa
基金
新加坡国家研究基金会;
关键词
L-Carnitine L-tartrate; Pheroid (TM); Skin aging; Topical delivery; SKIN; DIFFERENTIATION; KERATINOCYTES; PENETRATION; TRANSPORTER; SENESCENCE; ACID;
D O I
10.1159/000330385
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: The two types of skin aging (intrinsic and extrinsic) share important molecular features, while having distinct differences on the macromolecular level: both lead to increased production of reactive oxygen species, enhanced matrix metalloproteinase expression and decreased procollagen synthesis. L-Carnitine L-tartrate has been reported to have anti-aging effects. Aim and Methods: The delivery as well as the transport of L-carnitine to the target sites, i.e. stratum corneum and epidermis-dermis of female abdominal skin, with and without the use of Pheroid (TM) as delivery system, were investigated during this study by use of Franz diffusion cells and analysed by liquid chromatography/mass spectrometry. The presence of endogenous L-carnitine in human skin was also investigated. Results and Conclusion: The Pheroid (TM) delivery system enhanced the diffusion of L-carnitine through the skin, although the phosphate buffer solution (PBS) showed a higher concentration of the active agent in the skin layers. This could be because Pheroid, being more lipophilic than PBS, improved the diffusion of L-carnitine through the skin layers, consequently leading to a lesser amount of L-carnitine delivered to the target site, i.e. the epidermis-dermis. Copyright (C) 2011 S. Karger AG, Basel
引用
收藏
页码:330 / 336
页数:7
相关论文
共 50 条
  • [1] DHA and L-carnitine loaded chitosan hydrogels as delivery systems for topical applications
    Sole, Isabel
    Vilchez, Susana
    Miras, Jonathan
    Montanya, Nliria
    Jose Garcia-Celma, Maria
    Esquena, Jordi
    [J]. COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS, 2017, 525 : 85 - 92
  • [2] L-carnitine for two - The role of L-carnitine in pregnancy
    Held, Ulla
    [J]. AGRO FOOD INDUSTRY HI-TECH, 2006, 17 (01): : 7 - 9
  • [3] L-Carnitine
    Walter, JH
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 1996, 74 (06) : 475 - 478
  • [4] L-Carnitine
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2004, 46 (1196): : 95 - +
  • [5] L-CARNITINE
    SHORTLAND, GJ
    WALTER, JH
    [J]. LANCET, 1990, 335 (8699): : 1215 - 1215
  • [6] L-carnitine
    不详
    [J]. ALTERNATIVE MEDICINE REVIEW, 2005, 10 (01) : 42 - 50
  • [7] BUTYROBETAINE IS EQUAL TO L-CARNITINE IN ELEVATING L-CARNITINE LEVELS IN RATS
    SANDOR, A
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1991, 1083 (02) : 135 - 138
  • [8] STUDIES ON THE KINETICS AND APPLICATION OF L-CARNITINE AMIDASE FOR THE PRODUCTION OF L-CARNITINE
    JOERES, U
    BOMMARIUS, AS
    THOMMES, J
    KULA, MR
    [J]. BIOCATALYSIS AND BIOTRANSFORMATION, 1995, 12 (01) : 27 - 36
  • [9] Topical administration of L-carnitine on prevention and treatment of murine dry eye
    Garrett, Qian
    Zhang, Xin
    Wang, Yu
    Simmons, Peter
    Vehige, Joseph
    Li, Jinyang
    Chen, Wei
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [10] Pharmacokinetics of L-Carnitine
    Allan M. Evans
    Gianfranco Fornasini
    [J]. Clinical Pharmacokinetics, 2003, 42 : 941 - 967